{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:26:13Z","timestamp":1792517173763,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008426","name":"Friedrich-Baur-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00432-021-03838-6","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T14:02:59Z","timestamp":1636120979000},"page":"377-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia"],"prefix":"10.1007","volume":"148","author":[{"given":"Aurelia","family":"Vattai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Meister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Keilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Temelkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Heidegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Schmoeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Jeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hertlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kolben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"issue":"1","key":"3838_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-0897.2008.00590.x","volume":"60","author":"S Adurthi","year":"2008","unstructured":"Adurthi S, Krishna S, Mukherjee G, Bafna UD, Devi U, Jayshree RS (2008) Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma. Am J Reprod Immunol 60(1):55\u201365. https:\/\/doi.org\/10.1111\/j.1600-0897.2008.00590.x","journal-title":"Am J Reprod Immunol"},{"key":"3838_CR2","doi-asserted-by":"publisher","first-page":"a1284","DOI":"10.1136\/bmj.a1284","volume":"337","author":"M Arbyn","year":"2008","unstructured":"Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, Prendiville W, Paraskevaidis E (2008) Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ (clin Res Ed) 337:a1284. https:\/\/doi.org\/10.1136\/bmj.a1284","journal-title":"BMJ (clin Res Ed)"},{"issue":"2","key":"3838_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/jcp.51.2.96","volume":"51","author":"MJ Arends","year":"1998","unstructured":"Arends MJ, Buckley CH, Wells M (1998) Aetiology, pathogenesis, and pathology of cervical neoplasia. J Clin Pathol 51(2):96\u2013103. https:\/\/doi.org\/10.1136\/jcp.51.2.96","journal-title":"J Clin Pathol"},{"issue":"12","key":"3838_CR4","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.jid.2019.03.1162","volume":"139","author":"AA Bashaw","year":"2019","unstructured":"Bashaw AA, Teoh SM, Tuong ZK, Leggatt GR, Frazer IH, Chandra J (2019) HPV16 E7-Driven Epithelial Hyperplasia Promotes Impaired Antigen Presentation and Regulatory T-Cell Development. J Invest Dermatol 139(12):2467-2476.e2463. https:\/\/doi.org\/10.1016\/j.jid.2019.03.1162","journal-title":"J Invest Dermatol"},{"issue":"2","key":"3838_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jmv.25312","volume":"91","author":"CM Bonin","year":"2019","unstructured":"Bonin CM, Padovani CTJ, da Costa IP, \u00c1vila LS, Ferreira AMT, Fernandes CES, Dos Santos AR, Tozetti IA (2019) Detection of regulatory T cell phenotypic markers and cytokines in patients with human papillomavirus infection. J Med Virol 91(2):317\u2013325. https:\/\/doi.org\/10.1002\/jmv.25312","journal-title":"J Med Virol"},{"key":"3838_CR6","unstructured":"Boyer SN, Wazer DE, Band V (1996) E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56(20):4620\u20134624. https:\/\/cancerres.aacrjournals.org\/content\/canres\/56\/20\/4620.full.pdf"},{"issue":"10","key":"3838_CR7","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1073\/pnas.89.10.4549","volume":"89","author":"S Chellappan","year":"1992","unstructured":"Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, Nevins JR (1992) Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA 89(10):4549\u20134553. https:\/\/doi.org\/10.1073\/pnas.89.10.4549","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"3838_CR8","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1200\/jco.18.01265","volume":"37","author":"HC Chung","year":"2019","unstructured":"Chung HC, Ros W, Delord JP, Perets R, Italiano A, Shapira-Frommer R, Manzuk L, Piha-Paul SA, Xu L, Zeigenfuss S, Pruitt SK, Leary A (2019) Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol 37(17):1470\u20131478. https:\/\/doi.org\/10.1200\/jco.18.01265","journal-title":"J Clin Oncol"},{"key":"3838_CR9","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.3389\/fimmu.2019.03136","volume":"10","author":"A Colamatteo","year":"2020","unstructured":"Colamatteo A, Carbone F, Bruzzaniti S, Galgani M, Fusco C, Maniscalco GT, Di Rella F, de Candia P, De Rosa V (2020) Molecular mechanisms controlling Foxp3 expression in health and autoimmunity: from epigenetic to post-translational regulation. Front Immunol 10:3136\u20133136. https:\/\/doi.org\/10.3389\/fimmu.2019.03136","journal-title":"Front Immunol"},{"issue":"2","key":"3838_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.coi.2008.04.008","volume":"20","author":"TJ Curiel","year":"2008","unstructured":"Curiel TJ (2008) Regulatory T cells and treatment of cancer. Curr Opin Immunol 20(2):241\u2013246. https:\/\/doi.org\/10.1016\/j.coi.2008.04.008","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"3838_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10(9):942\u2013949. https:\/\/doi.org\/10.1038\/nm1093","journal-title":"Nat Med"},{"issue":"3","key":"3838_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","volume":"16","author":"TM Darragh","year":"2012","unstructured":"Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wilkinson EJ, Zaino RJ, Wilbur DC (2012) The lower anogenital squamous terminology standardization project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis 16(3):205\u2013242. https:\/\/doi.org\/10.1097\/LGT.0b013e31825c31dd","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"3838_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ygyno.2009.03.022","volume":"114","author":"RA De Jong","year":"2009","unstructured":"De Jong RA et al (2009) Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol 114(1):105\u2013110","journal-title":"Gynecol Oncol"},{"issue":"8","key":"3838_CR14","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s10585-013-9602-9","volume":"30","author":"L Demir","year":"2013","unstructured":"Demir L, Yigit S, Ellidokuz H, Erten C, Somali I, Kucukzeybek Y, Alacacioglu A, Cokmert S, Can A, Akyol M, Dirican A, Bayoglu V, Sari AA, Tarhan MO (2013) Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clin Exp Metastasis 30(8):1047\u20131062. https:\/\/doi.org\/10.1007\/s10585-013-9602-9","journal-title":"Clin Exp Metastasis"},{"issue":"16","key":"3838_CR15","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1158\/1078-0432.Ccr-10-1073","volume":"16","author":"L Deng","year":"2010","unstructured":"Deng L, Zhang H, Luan Y, Zhang J, Xing Q, Dong S, Wu X, Liu M, Wang S (2010) Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients. Clin Cancer Res 16(16):4105\u20134112. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-1073","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3838_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/path.4381","volume":"234","author":"S Douglass","year":"2014","unstructured":"Douglass S, Meeson AP, Overbeck-Zubrzycka D, Brain JG, Bennett MR, Lamb CA, Lennard TW, Browell D, Ali S, Kirby JA (2014) Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12. J Pathol 234(1):74\u201385. https:\/\/doi.org\/10.1002\/path.4381","journal-title":"J Pathol"},{"key":"3838_CR17","unstructured":"Fischer L, Heinemann V (2020) Checkpoint-Inhibitoren bei Plattenepithelkarzinomen - Im Fokus: HNO-, Zervix- und Analkarzinome. Trillium Krebsmedizin, 02"},{"issue":"36","key":"3838_CR18","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1200\/jco.2017.74.5471","volume":"35","author":"JS Frenel","year":"2017","unstructured":"Frenel JS, Le Tourneau C, O\u2019Neil B, Ott PA, Piha-Paul SA, Gomez-Roca C, van Brummelen EMJ, Rugo HS, Thomas S, Saraf S, Rangwala R, Varga A (2017) Safety and efficacy of pembrolizumab in advanced, programmed death ligand 1-positive cervical cancer: results from the phase Ib KEYNOTE-028 trial. J Clin Oncol 35(36):4035\u20134041. https:\/\/doi.org\/10.1200\/jco.2017.74.5471","journal-title":"J Clin Oncol"},{"issue":"7","key":"3838_CR19","doi-asserted-by":"publisher","first-page":"1593806","DOI":"10.1080\/2162402X.2019.1593806","volume":"8","author":"Q Fu","year":"2019","unstructured":"Fu Q, Chen N, Ge C, Li R, Li Z, Zeng B, Li C, Wang Y, Xue Y, Song X, Li H, Li G (2019) Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis. Oncoimmunology 8(7):1593806\u20131593806. https:\/\/doi.org\/10.1080\/2162402X.2019.1593806","journal-title":"Oncoimmunology"},{"issue":"1","key":"3838_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.virol.2003.08.008","volume":"317","author":"S Gupta","year":"2003","unstructured":"Gupta S, Takhar PPS, Degenkolbe R, Heng Koh C, Zimmermann H, Maolin Yang C, Guan Sim K, I-Hong Hsu S, Bernard H-U (2003) The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br 1. Virology 317(1):155\u2013164. https:\/\/doi.org\/10.1016\/j.virol.2003.08.008","journal-title":"Virology"},{"issue":"1","key":"3838_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41590-019-0555-2","volume":"21","author":"A Hatzioannou","year":"2020","unstructured":"Hatzioannou A, Banos A, Sakelaropoulos T, Fedonidis C, Vidali MS, K\u00f6hne M, H\u00e4ndler K, Boon L, Henriques A, Koliaraki V, Georgiadis P, Zoidakis J, Termentzi A, Beyer M, Chavakis T, Boumpas D, Tsirigos A, Verginis P (2020) An intrinsic role of IL-33 in T(reg) cell-mediated tumor immunoevasion. Nat Immunol 21(1):75\u201385. https:\/\/doi.org\/10.1038\/s41590-019-0555-2","journal-title":"Nat Immunol"},{"key":"3838_CR22","doi-asserted-by":"publisher","first-page":"8344","DOI":"10.1158\/0008-5472.CAN-06-3304","volume":"67","author":"S Hinz","year":"2007","unstructured":"Hinz S (2007) Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Can Res 67:8344\u20138350","journal-title":"Can Res"},{"issue":"2","key":"3838_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00345-015-1615-3","volume":"34","author":"T Horn","year":"2016","unstructured":"Horn T, Laus J, Seitz AK, Maurer T, Schmid SC, Wolf P, Haller B, Winkler M, Retz M, Nawroth R, Gschwend JE, K\u00fcbler HR, Slotta-Huspenina J (2016) The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer. World J Urol 34(2):181\u2013187. https:\/\/doi.org\/10.1007\/s00345-015-1615-3","journal-title":"World J Urol"},{"issue":"6","key":"3838_CR24","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3349\/ymj.2008.49.6.942","volume":"49","author":"TJ Jang","year":"2008","unstructured":"Jang TJ (2008) Prevalence of Foxp3 positive T regulatory cells is increased during progression of cutaneous squamous tumors. Yonsei Med J 49(6):942\u2013948. https:\/\/doi.org\/10.3349\/ymj.2008.49.6.942","journal-title":"Yonsei Med J"},{"key":"3838_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3389\/fimmu.2019.00911","volume":"10","author":"N J\u00f8rgensen","year":"2019","unstructured":"J\u00f8rgensen N, Persson G, Hviid TVF (2019) The tolerogenic function of regulatory T cells in pregnancy and cancer. Front Immunol 10:911. https:\/\/doi.org\/10.3389\/fimmu.2019.00911","journal-title":"Front Immunol"},{"issue":"11","key":"3838_CR26","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1158\/1078-0432.Ccr-18-2740","volume":"25","author":"KH Jung","year":"2019","unstructured":"Jung KH, LoRusso P, Burris H, Gordon M, Bang YJ, Hellmann MD, Cervantes A, de Olza MO, Marabelle A, Hodi FS, Ahn MJ, Emens LA, Barlesi F, Hamid O, Calvo E, McDermott D, Soliman H, Rhee I, Lin R, Pourmohamad T, Suchomel J, Tsuhako A, Morrissey K, Mahrus S, Morley R, Pirzkall A, Davis SL (2019) Phase I study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) administered with PD-L1 inhibitor (atezolizumab) in advanced solid tumors. Clin Cancer Res 25(11):3220\u20133228. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-2740","journal-title":"Clin Cancer Res"},{"issue":"12","key":"3838_CR27","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00262-015-1753-x","volume":"64","author":"KL Knutson","year":"2015","unstructured":"Knutson KL, Maurer MJ, Preston CC, Moysich KB, Goergen K, Hawthorne KM, Cunningham JM, Odunsi K, Hartmann LC, Kalli KR, Oberg AL, Goode EL (2015) Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer. Cancer Immunol Immunother 64(12):1495\u20131504. https:\/\/doi.org\/10.1007\/s00262-015-1753-x","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"3838_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/aji.12030","volume":"69","author":"S Kojima","year":"2013","unstructured":"Kojima S, Kawana K, Tomio K, Yamashita A, Taguchi A, Miura S, Adachi K, Nagamatsu T, Nagasaka K, Matsumoto Y, Arimoto T, Oda K, Wada-Hiraike O, Yano T, Taketani Y, Fujii T, Schust DJ, Kozuma S (2013) The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN. Am J Reprod Immunol 69(2):134\u2013141. https:\/\/doi.org\/10.1111\/aji.12030","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"3838_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2217\/fon-2016-0259","volume":"13","author":"TM Kolben","year":"2017","unstructured":"Kolben TM, Kraft F, Kolben T, Goess C, Semmlinger A, Dannecker C, Schmoeckel E, Mayr D, Sommer NN, Mahner S, Jeschke U (2017) Expression of Sialyl Lewis a, Sialyl Lewis x, Lewis y, Gal-3, Gal-7, STMN1 and p16 in cervical dysplasia. Future Oncol 13(2):145\u2013157. https:\/\/doi.org\/10.2217\/fon-2016-0259","journal-title":"Future Oncol"},{"key":"3838_CR30","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e42","author":"TM Kolben","year":"2019","unstructured":"Kolben TM, Etzel LT, Bergauer F, Hagemann I, Hillemanns P, Repper M, Kaufmann AM, Sotlar K, Kolben T, Helms H-J, Gallwas J, Mahner S, Dannecker C (2019) A randomized trial comparing limited-excision conisation to Large Loop Excision of the Transformation Zone (LLETZ) in cervical dysplasia patients. J Gynecol Oncol. https:\/\/doi.org\/10.3802\/jgo.2019.30.e42","journal-title":"J Gynecol Oncol"},{"issue":"6","key":"3838_CR31","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1073\/pnas.0811556106","volume":"106","author":"N Komatsu","year":"2009","unstructured":"Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S (2009) Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA 106(6):1903\u20131908. https:\/\/doi.org\/10.1073\/pnas.0811556106","journal-title":"Proc Natl Acad Sci USA"},{"key":"3838_CR32","doi-asserted-by":"publisher","first-page":"i3633","DOI":"10.1136\/bmj.i3633","volume":"354","author":"M Kyrgiou","year":"2016","unstructured":"Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, Arbyn M, Bennett P, Paraskevaidis E (2016) Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ (clin Res Ed) 354:i3633\u2013i3633. https:\/\/doi.org\/10.1136\/bmj.i3633","journal-title":"BMJ (clin Res Ed)"},{"issue":"14","key":"3838_CR33","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","volume":"383","author":"J Lei","year":"2020","unstructured":"Lei J, Ploner A, Elfstr\u00f6m KM, Wang J, Roth A, Fang F, Sundstr\u00f6m K, Dillner J, Spar\u00e9n P (2020) HPV vaccination and the risk of invasive cervical cancer. N Engl J Med 383(14):1340\u20131348. https:\/\/doi.org\/10.1056\/NEJMoa1917338","journal-title":"N Engl J Med"},{"issue":"7","key":"3838_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41419-018-0790-8","volume":"9","author":"X Li","year":"2018","unstructured":"Li X, Gao Y, Li J, Zhang K, Han J, Li W, Hao Q, Zhang W, Wang S, Zeng C, Zhang W, Zhang Y, Li M, Zhang C (2018) FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer. Cell Death Dis 9(7):744\u2013744. https:\/\/doi.org\/10.1038\/s41419-018-0790-8","journal-title":"Cell Death Dis"},{"issue":"6","key":"3838_CR35","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1349-7006.2009.01153.x","volume":"100","author":"C Loddenkemper","year":"2009","unstructured":"Loddenkemper C, Hoffmann C, Stanke J, Nagorsen D, Baron U, Olek S, Huehn J, Ritz J-P, Stein H, Kaufmann AM, Schneider A, Cichon G (2009) Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci 100(6):1112\u20131117. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01153.x","journal-title":"Cancer Sci"},{"issue":"3","key":"3838_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","volume":"13","author":"M Miyara","year":"2007","unstructured":"Miyara M, Sakaguchi S (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13(3):108\u2013116. https:\/\/doi.org\/10.1016\/j.molmed.2007.01.003","journal-title":"Trends Mol Med"},{"issue":"31","key":"3838_CR37","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/jco.19.00739","volume":"37","author":"RW Naumann","year":"2019","unstructured":"Naumann RW, Hollebecque A, Meyer T, Devlin MJ, Oaknin A, Kerger J, L\u00f3pez-Picazo JM, Machiels JP, Delord JP, Evans TRJ, Boni V, Calvo E, Topalian SL, Chen T, Soumaoro I, Li B, Gu J, Zwirtes R, Moore KN (2019) Safety and efficacy of nivolumab monotherapy in recurrent or metastatic cervical, vaginal, or vulvar carcinoma: results from the phase I\/II checkmate 358 trial. J Clin Oncol 37(31):2825\u20132834. https:\/\/doi.org\/10.1200\/jco.19.00739","journal-title":"J Clin Oncol"},{"key":"3838_CR38","unstructured":"NCCN-Guidelines\u00ae (2020) NCCN Clinical Practice Guidelines in Oncology. Cervical Cancer. Retrieved January 14"},{"issue":"7","key":"3838_CR39","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/cas.14069","volume":"110","author":"Y Ohue","year":"2019","unstructured":"Ohue Y, Nishikawa H (2019) Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? Cancer Sci 110(7):2080\u20132089. https:\/\/doi.org\/10.1111\/cas.14069","journal-title":"Cancer Sci"},{"key":"3838_CR40","first-page":"3128","volume":"59","author":"S Onizuka","year":"1999","unstructured":"Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Can Res 59:3128\u20133133","journal-title":"Can Res"},{"issue":"1","key":"3838_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0090-8258(92)90483-Y","volume":"45","author":"E Paraskevaidis","year":"1992","unstructured":"Paraskevaidis E et al (1992) A population-based study of microinvasive disease of the cervix\u2013a colposcopic and cytologic analysis. Gynecol Oncol 45(1):9\u201312","journal-title":"Gynecol Oncol"},{"issue":"8","key":"3838_CR42","first-page":"5039","volume":"11","author":"GL Peng","year":"2019","unstructured":"Peng GL, Li L, Guo YW, Yu P, Yin XJ, Wang S, Liu CP (2019) CD8(+) cytotoxic and FoxP3(+) regulatory T lymphocytes serve as prognostic factors in breast cancer. Am J Transl Res 11(8):5039\u20135053","journal-title":"Am J Transl Res"},{"issue":"13","key":"3838_CR43","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.ejca.2008.05.017","volume":"44","author":"G Perrone","year":"2008","unstructured":"Perrone G, Ruffini PA, Catalano V, Spino C, Santini D, Muretto P, Spoto C, Zingaretti C, Sisti V, Alessandroni P, Giordani P, Cicetti A, D\u2019Emidio S, Morini S, Ruzzo A, Magnani M, Tonini G, Rabitti C, Graziano F (2008) Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. Eur J Cancer 44(13):1875\u20131882. https:\/\/doi.org\/10.1016\/j.ejca.2008.05.017","journal-title":"Eur J Cancer"},{"issue":"1","key":"3838_CR44","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","volume":"241","author":"AY Rudensky","year":"2011","unstructured":"Rudensky AY (2011) Regulatory T cells and Foxp3. Immunol Rev 241(1):260\u2013268. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01018.x","journal-title":"Immunol Rev"},{"issue":"51","key":"3838_CR45","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"Sato E et al (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102(51):18538\u201318543","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3838_CR46","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63(6):1129\u20131136. https:\/\/doi.org\/10.1016\/0092-8674(90)90409-8","journal-title":"Cell"},{"issue":"4","key":"3838_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1158\/1055-9965.EPI-12-1406","volume":"22","author":"M Schiffman","year":"2013","unstructured":"Schiffman M, Wentzensen N (2013) Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. CEBP Focus 22(4):553\u2013560. https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-1406","journal-title":"CEBP Focus"},{"issue":"5","key":"3838_CR48","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1084\/jem.20041982","volume":"201","author":"R Setoguchi","year":"2005","unstructured":"Setoguchi R, Hori S, Takahashi T, Sakaguchi S (2005) Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201(5):723\u2013735. https:\/\/doi.org\/10.1084\/jem.20041982","journal-title":"J Exp Med"},{"issue":"1","key":"3838_CR49","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12885-017-3633-6","volume":"17","author":"J-Y Shi","year":"2017","unstructured":"Shi J-Y, Ma L-J, Zhang J-W, Duan M, Ding Z-B, Yang L-X, Cao Y, Zhou J, Fan J, Zhang X, Zhao Y-J, Wang X-Y, Gao Q (2017) FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-\u03b2\/Smad2\/3 signaling pathway. BMC Cancer 17(1):648\u2013648. https:\/\/doi.org\/10.1186\/s12885-017-3633-6","journal-title":"BMC Cancer"},{"issue":"3","key":"3838_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/1940-6207.CAPR-17-0293","volume":"11","author":"MI Silver","year":"2018","unstructured":"Silver MI, Gage JC, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Katki HA, Locke A, Kinney WK, Castle PE (2018) Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21\u201339 years. Cancer Prev Res 11(3):165\u2013170. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-17-0293","journal-title":"Cancer Prev Res"},{"key":"3838_CR51","doi-asserted-by":"publisher","first-page":"k499","DOI":"10.1136\/bmj.k499","volume":"360","author":"K Tainio","year":"2018","unstructured":"Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, C\u00e1rdenas J, Hern\u00e1ndes Glazer-Livson S, Jakobsson M, Joronen K, Kiviharju M, Louvanto K, Oksjoki S, T\u00e4htinen R, Virtanen S, Nieminen P, Kyrgiou M, Kalliala I (2018) Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. The BMJ 360:k499. https:\/\/doi.org\/10.1136\/bmj.k499","journal-title":"The BMJ"},{"issue":"1","key":"3838_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12957-017-1221-5","volume":"15","author":"J Tang","year":"2017","unstructured":"Tang J, Yang Z, Wang Z, Li Z, Li H, Yin J, Deng M, Zhu W, Zeng C (2017) Foxp3 is correlated with VEGF-C expression and lymphangiogenesis in cervical cancer. World J Surg Oncol 15(1):173\u2013173. https:\/\/doi.org\/10.1186\/s12957-017-1221-5","journal-title":"World J Surg Oncol"},{"issue":"2","key":"3838_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2015.1064581","volume":"5","author":"E Vacchelli","year":"2016","unstructured":"Vacchelli E, Semeraro M, Adam J, Dartigues P, Zitvogel L, Kroemer G (2016) Immunosurveillance in esophageal carcinoma: the decisive impact of regulatory T cells. Oncoimmunology 5(2):e1064581. https:\/\/doi.org\/10.1080\/2162402x.2015.1064581","journal-title":"Oncoimmunology"},{"issue":"2","key":"3838_CR54","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2249.2007.03468.x","volume":"150","author":"J Visser","year":"2007","unstructured":"Visser J, Nijman HW, Hoogenboom BN, Jager P, van Baarle D, Schuuring E, Abdulahad W, Miedema F, van der Zee AG, Daemen T (2007) Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia. Clin Exp Immunol 150(2):199\u2013209. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03468.x","journal-title":"Clin Exp Immunol"},{"key":"3838_CR55","doi-asserted-by":"publisher","unstructured":"Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Mu\u00f1oz N (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12\u201319. https:\/\/doi.org\/10.1002\/(sici)1096-9896(199909)189:1<12::Aid-path431>3.0.Co;2-f","DOI":"10.1002\/(sici)1096-9896(199909)189:1<12::Aid-path431>3.0.Co;2-f"},{"key":"3838_CR56","unstructured":"Wang L, Liu R, Ribick M, Zheng P, Liu Y (2010) FOXP3 as an X-linked tumor suppressor. Discov Med 10(53):322\u2013328. https:\/\/pubmed.ncbi.nlm.nih.gov\/21034673. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4500105\/"},{"issue":"6","key":"3838_CR57","doi-asserted-by":"publisher","first-page":"769.e761","DOI":"10.1016\/j.ajog.2015.01.010","volume":"212","author":"TM Wilkinson","year":"2015","unstructured":"Wilkinson TM, Sykes PH, Simcock B, Petrich S (2015) Recurrence of high-grade cervical abnormalities following conservative management of cervical intraepithelial neoplasia grade 2. Am J Obstet Gynecol 212(6):769.e761\u2013767. https:\/\/doi.org\/10.1016\/j.ajog.2015.01.010","journal-title":"Am J Obstet Gynecol"},{"issue":"16","key":"3838_CR58","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s00018-009-0026-2","volume":"66","author":"CJ Workman","year":"2009","unstructured":"Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DAA (2009) The development and function of regulatory T cells. Cell Mol Life Sci CMLS 66(16):2603\u20132622. https:\/\/doi.org\/10.1007\/s00018-009-0026-2","journal-title":"Cell Mol Life Sci CMLS"},{"key":"3838_CR59","unstructured":"WorldHealthOrganization (2020) World Health Assembly adopts global strategy to accelerate cervical cancer elimination. Retrieved 26 Oct 2020 from https:\/\/www.who.int\/news\/item\/19-08-2020-world-health-assembly-adopts-global-strategy-to-accelerate-cervical-cancer-elimination"},{"issue":"7","key":"3838_CR60","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1158\/0008-5472.CAN-18-2049","volume":"79","author":"L Wu","year":"2019","unstructured":"Wu L, Yi B, Wei S, Rao D, He Y, Naik G, Bae S, Liu XM, Yang W-H, Sonpavde G, Liu R, Wang L (2019) Loss of FOXP3 and TSC1 accelerates prostate cancer progression through synergistic transcriptional and posttranslational regulation of c-MYC. Cancer Res 79(7):1413\u20131425. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2049","journal-title":"Cancer Res"},{"issue":"1","key":"3838_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41419-020-03272-5","volume":"12","author":"R Xu","year":"2021","unstructured":"Xu R, Wu M, Liu S, Shang W, Li R, Xu J, Huang L, Wang F (2021) Glucose metabolism characteristics and TLR8-mediated metabolic control of CD4(+) Treg cells in ovarian cancer cells microenvironment. Cell Death Dis 12(1):22. https:\/\/doi.org\/10.1038\/s41419-020-03272-5","journal-title":"Cell Death Dis"},{"issue":"7","key":"3838_CR62","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/ijc.32782","volume":"146","author":"H Yang","year":"2020","unstructured":"Yang H, Ye S, Goswami S, Li T, Wu J, Cao C, Ma J, Lu B, Pei X, Chen Y, Yu J, Xu H, Qiu L, Afridi S, Xiang L, Zhang X (2020) Highly immunosuppressive HLADR(hi) regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma. Int J Cancer 146(7):1993\u20132006. https:\/\/doi.org\/10.1002\/ijc.32782","journal-title":"Int J Cancer"},{"issue":"3","key":"3838_CR63","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/imm.13067","volume":"157","author":"H Yano","year":"2019","unstructured":"Yano H, Andrews LP, Workman CJ, Vignali DAA (2019) Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity. Immunology 157(3):232\u2013247. https:\/\/doi.org\/10.1111\/imm.13067","journal-title":"Immunology"},{"issue":"5","key":"3838_CR64","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1084\/jem.20041684","volume":"201","author":"P Yu","year":"2005","unstructured":"Yu P, Lee Y, Liu W, Krausz T, Chong A, Schreiber H, Fu Y-X (2005) Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 201(5):779\u2013791. https:\/\/doi.org\/10.1084\/jem.20041684","journal-title":"J Exp Med"},{"issue":"3","key":"3838_CR65","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00262-012-1348-8","volume":"62","author":"C Zeng","year":"2013","unstructured":"Zeng C, Yao Y, Jie W, Zhang M, Hu X, Zhao Y, Wang S, Yin J, Song Y (2013) Up-regulation of Foxp3 participates in progression of cervical cancer. Cancer Immunol Immunother 62(3):481\u2013487. https:\/\/doi.org\/10.1007\/s00262-012-1348-8","journal-title":"Cancer Immunol Immunother"},{"key":"3838_CR66","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23581","author":"T Zhang","year":"2017","unstructured":"Zhang T, Jiao J, Jiao X, Zhao L, Tian X, Zhang Q, Ma D, Cui B (2017) Aberrant frequency of TNFR2 + Treg and related cytokines in patients with CIN and cervical cancer. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.23581","journal-title":"Oncotarget"},{"issue":"50","key":"3838_CR67","doi-asserted-by":"publisher","first-page":"e18403","DOI":"10.1097\/MD.0000000000018403","volume":"98","author":"X Zhao","year":"2019","unstructured":"Zhao X, Li Y, Wang X, Wu J, Yuan Y, Lv S, Ren J (2019) Synergistic association of FOXP3+ tumor infiltrating lymphocytes with CCL20 expressions with poor prognosis of primary breast cancer: a retrospective cohort study. Medicine 98(50):e18403\u2013e18403. https:\/\/doi.org\/10.1097\/MD.0000000000018403","journal-title":"Medicine"},{"issue":"12","key":"3838_CR68","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1172\/JCI32538","volume":"117","author":"T Zuo","year":"2007","unstructured":"Zuo T, Liu R, Zhang H, Chang X, Liu Y, Wang L, Zheng P, Liu Y (2007) FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Investig 117(12):3765\u20133773. https:\/\/doi.org\/10.1172\/JCI32538","journal-title":"J Clin Investig"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03838-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03838-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03838-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T19:04:26Z","timestamp":1643483066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03838-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3838"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03838-6","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"24 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sven Mahner: Research support, advisory board Honoria and travel expenses from AbbVie, Astra Zeneca, Clovis, Eisai, GSK, Medac, MSD, Novartis, Olympus, PharmaMar, Roche, Sensor Kinesis, Teva, Tesaro. Thomas Kolben: Holding stocks of Roche AG, relative working at Roche AG. Anna Hester: Honoraria and travel expenses from Pfizer, Honoraria from Roche, Research funding from \u201cWalter-Schulz-Stiftung\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients gave informed consent prior to study participation. All procedures were performed according to the ethical standards of the institutional and\/or national research committee and with the declaration of Helsinki of 1964 and its later amendments. This study was approved by the local ethics committee of the Ludwig-Maximilians-University Munich, Germany (167-14).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}